SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention after a steep selloff amid no confirmed company update; traders debate whether broad biotech weakness and options-related trading drove the drop or whether the companys prolonged silence is adding pressure. The central catalyst remains the blinded Phase 3 REGAL trial, last reported at 78 of 80 required events: bulls see the slow event pace as a possible sign of longer survival, while bears question the delay, trial design, and prospects for a successful readout.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is drawing attention amid a sharp selloff across semiconductor and AI-linked stocks, with traders debating whether concerns about AI spending, inflation and broader market risk point to further weakness or an oversold pullback. Bulls point to Intels foundry prospects and upcoming earnings, while bears question its valuation and warn the selling may continue.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

ESMO data on lifileucel is driving attention: traders are weighing mature frontline melanoma results and early sarcoma responses as encouraging signs, while noting the small cohorts and need for confirmation in larger trials. The sharp pullback is widely viewed in the discussion as part of broader biotech and market weakness rather than a clear company-specific reaction.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

A sharp futures rebound after Fridays selloff has dominated discussion, pushing back against widespread Black Monday crash fears. Bulls view the move as a relief rally or short squeeze, while skeptics call it a low-volume bull trap and question whether it will hold; some traders also speculate that Russia-related diesel and peace-talk headlines are helping sentiment.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention after a sharp semiconductor selloff, amplified by its 3x daily leverage, amid concerns about AI spending and debt, Chinese competition, and persistent inflation. Traders are split between buying the steep dip and expecting a rebound, and warning that selling and forced liquidations may continue.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp tech- and AI-linked selloff followed by a strong futures rebound, with traders split over whether the bounce signals recovery or is a short-covering rally that could fade. Crash warnings, including Black Monday talk, are competing with optimism ahead of major tech earnings.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

A sharp selloff across neocloud and AI-infrastructure stocks, driven by worries about debt, financing costs, and whether heavy data-center spending will pay off, is weighing on Nebius. Traders are divided: bears see more downside as the sector faces a valuation reset, while bulls argue Nebius is financially stronger than some peers and the pullback is overdone.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Deltas quarterly earnings miss and reduced full-year outlook, driven by sharply higher fuel costs, are the main focus. Traders are split over whether strong travel and premium demand can offset margin pressure, with bulls pointing to pricing power and possible fuel relief while bears worry about further earnings weakness.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

KWEB is drawing attention amid continued weakness in Chinese internet stocks, with traders split between buying the oversold pullback and expecting further declines. Bulls cite support levels and Chinas AI potential, while skeptics point to prolonged underperformance versus U.S. tech, weak domestic demand, regulatory and geopolitical risks, and a lack of sustained inflows.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

A sharp AI-sector selloff and concerns about Super Micros governance and export-control risks are driving attention as the stock posts steep losses. Bulls call the decline an oversold buying opportunity and point to expected earnings and AI demand, while bears worry about compliance issues, management credibility, and a possible slowdown in AI spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

First Interstate BancSystem (FIBK) Reports Next Week: Wall Street Expects Earnings Growth

First Interstate BancSystem (FIBK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Old Second Bancorp (OSBC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Old Second Bancorp (OSBC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Old Second Bancorp (OSBC) Moves to Buy: Rationale Behind the Upgrade

Old Second Bancorp (OSBC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Old Second Bancorp (OSBC) Upgraded to Strong Buy: Here's Why

Old Second Bancorp (OSBC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Are You Looking for a Top Momentum Pick? Why Old Second Bancorp (OSBC) is a Great Choice

Does Old Second Bancorp (OSBC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Old Second Bancorp (OSBC) Q2 Earnings and Revenues Top Estimates

Old Second Bancorp (OSBC) delivered earnings and revenue surprises of +1.85% and +1.57%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Compared to Estimates, Old Second Bancorp (OSBC) Q2 Earnings: A Look at Key Metrics

The headline numbers for Old Second Bancorp (OSBC) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

First Western (MYFW) Earnings Expected to Grow: Should You Buy?

First Western (MYFW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are Options Traders Betting on a Big Move in Old Second Bancorp Stock?

Investors need to pay close attention to OSBC stock based on the movements in the options market lately.

Old Second Bancorp (OSBC) Reports Next Week: Wall Street Expects Earnings Growth

Old Second Bancorp (OSBC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Old Second Bancorp, Inc. is a bank holding company. It engages in the provision of traditional retail and commercial banking services through its wholly owned subsidiaries. Its services includes personal banking, loans, business banking, and wealth management. The firm operates through the community banking segment. The company was founded in 1981 and is headquartered in Aurora, IL.

Old Second Bancorporation Inc.

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$24.88
Prev Close	$24.85
Open	$24.93
Dividend Yield	1.28%
50-Day Moving Average	$25.15
Beta	0.78
Avg. Volume	482,536.66
PE Ratio	14.27

52-Week High	$26.06
52-Week Low	$17.08
Market Capitalization	$1.27B
EPS (Annual)	$1.62
Price to Book	1.40
Revenue Per Employee	$378,290.02

Feed

News

Sentiment

Earnings

Fundamentals

Info

OSBC Fundamentals